The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Licensing and Strategic Partnerships in Biotechnology and Pharma: Slides from Yesterday’s Talk

oceta-logo1I spoke yesterday along with Chris Hunter, a partner at Ogilvy, and Dr. Tony Cruz of Transition Therapeutics, ric-logo1about biotech, pharma and other licensing and strategic partnering relationships.  The talk was at the ninth of this year’s ten “Growing Your Business” seminars hosted by the RIC Centre and OCETA.  The RIC Centre website now has the slides available (pdf) in case you’re interested. Over 50 people attended — a mix of bankers, entrepreneurs and academics. Many thanks to Tony for coming out, and to Pam Banks and Sharon Dotan of the RIC Centre for organizing the event.

Bookmark and Share

About these ads

One response to “Licensing and Strategic Partnerships in Biotechnology and Pharma: Slides from Yesterday’s Talk

  1. Pingback: Novel Deal Structures Becoming More Common « The Cross-Border Biotech Blog

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 131 other followers